Las Vegas Sands Corp. Message Board
- Reply to
Looks like Tommie was right again. Took his advice and sold some more yesterday. yesssssssss eom
by comicguy8 •May 16, 2013 10:15 AMWhich only $3000 dollars a year can be carry forward. Good luck on your strategy.
-
And much of the Midwest experienced snow storms which would keep the slabs from going in. Imo, this will push these numbers into next months #'s. I'm staying long with MTG & RDN until the Fall and perhaps later.
-
Consider buy and hold for a year and a day+ and pay less on your capitol gains. RDN and MTG are stocks to hold.
- Reply to
Looks like Tommie was right again. Took his advice and sold some more yesterday. yesssssssss eom
by comicguy8 •May 16, 2013 10:15 AMAnd acquired the tax consequences.
-
In the new IIa Cohort trials that are just under way, they are treating 20/100 patients in order to stop the progression of the Mac Gen. A different trial is beginning any day now to treat Myopia (farsightedness), where in China 4X the people with Myopia go blind as they do with Mag Gen. Did I mention China....? This stock has the biggest risk/reward ratio of anything I have ever seen.
-
mining_phd • Apr 30, 2013 10:14 AM
wefwfo will never get his wife her implants now. LMAO
This is an example post that mining_phd posted here and on other boards. He must of read one of my post were I mentioned my wife has breast cancer and has recently had a Mastectomy as part of her treatment. Very cold hearted of him. -
Today is just the start of an otherwise rewarding march upward. Think about it, a single embryonic stem cell starts the process and is the building block of life. ACT has a patent on a non destructive process of harvesting these early stage stem cells, which means NO embryos are destroyed or harmed in any way. A single hESC stem cell can be manipulated into any part of the body, in this case, to replicate the dead rpe cells in the eyes which causes Macular Degeneration blindness, a type of blindness that up till today had no cure.
-
Up 15.56 % and 9x volume in the first 3 hours.
Trust me, this is only the start. -
Present day home starts are down but building permits up over 16%. The future is bright. I believe the starts are down because of the usual wet weather last month.
-
Go to their website and read the press releases regarding the FDA.
-
Then you better wait until (if) it goes down 30% before you buy back so you won't be killed with income taxes
- Reply to
Just when you thought you read the dumbest post, Ricknagra comes through with a dumber one. read his sycrf post
by mining_phd •May 15, 2013 10:00 PMmining is one sick and uniformed lowlife. Regardless of his comments regarding my wife's cancer, his bragging about having a PURPLE HEART Medal all the while degrading the American soldier is lower than low.
-
Why reload, or rather, why buy, sell and buy again. Have patience grasshopper.
-
I bought 1000 shares in 2005 to keep it on my radar. Regenerative medicine IS the future of medical industry. I now own 2.5 mil.
Do your own DD as this one treatment is just one of many that will be rolled out during the next few years. Think about it, a single embryonic stem cell starts the process and is the building block of life. ACT has a patent on a non destructive process of harvesting these early stage stem cells, which means NO embryos are destroyed or harmed in any way. A single hESC stem cell can be manipulated into any part of the body, in this case, to replicate the dead rpe cells in the eyes which causes Macular Degeneration blindness, a type of blindness that up till today had no cure. -
Put this ACTC on your watch list. Macular Degeneration is a 30 Billion Dollar unmet medical need in America alone and ACTC has the ONLY ongoing FDA approved hESC stem cell clinical trials. Going from 20/400 (hand motions only) to 20/40 is curing someone who was twice the limit of being legally blind to just half the limit of being in jeopardy of losing your drivers license (20/100).
Think on this. If you were blind what would you be willing to pay to be able to see again?
ACT Confirms Clinical Trial Participant Showed Improvement
in Vision from 20/400 to 20/40 Following Treatment
MARLBOROUGH, Mass. – May 16, 2013 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today confirmed that the vision of a patient enrolled in a clinical investigation of the company’s retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) has improved from 20/400 to 20/40 following treatment. The improvement was first reported on May 15, 2013, in a news article published by Reuters.
“We continue to be encouraged by the progress we see in our ongoing clinical investigations, though the results included in the article were confidential and not intended for publication at that time,” commented Gary Rabin, chairman and CEO of ACT. “Our plan is still to publish additional results from the clinical investigations when we have a significant aggregation of data.”
Put this ACTC on your watch list. Macular Degeneration is a 30 Billion Dollar unmet medical need in America alone and ACTC has the ONLY ongoing FDA approved hESC stem cell clinical trials. Going from 20/400 (hand motions only) to 20/40 is curing someone who was twice the limit of being legally blind to just half the limit of being in jeopardy of losing your drivers license (20/100).
Think on this. If you were blind what would you be willing to pay to be able to see again? -
ACT Confirms Clinical Trial Participant Showed Improvement
in Vision from 20/400 to 20/40 Following Treatment
MARLBOROUGH, Mass. – May 16, 2013 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today confirmed that the vision of a patient enrolled in a clinical investigation of the company’s retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) has improved from 20/400 to 20/40 following treatment. The improvement was first reported on May 15, 2013, in a news article published by Reuters.
“We continue to be encouraged by the progress we see in our ongoing clinical investigations, though the results included in the article were confidential and not intended for publication at that time,” commented Gary Rabin, chairman and CEO of ACT. “Our plan is still to publish additional results from the clinical investigations when we have a significant aggregation of data.”
Put this ACTC on your watch list. Macular Degeneration is a 30 Billion Dollar unmet medical need in America alone and ACTC has the ONLY ongoing FDA approved hESC stem cell clinical trials. Going from 20/400 (hand motions only) to 20/40 is curing someone who was twice the limit of being legally blind to just half the limit of being in jeopardy of losing your drivers license (20/100).
Think on this. If you were blind what would you be willing to pay to be able to see again? -
He raised his stakes in two other mortgage insurers, more than tripling his holdings in Radian Group Inc to 11.5 million shares from 3.5 million shares, and raising his holdings in Genworth Financial Inc to 9 million shares from 3.9 million shares.
-
He raised his stakes in two other mortgage insurers, more than tripling his holdings in Radian Group Inc to 11.5 million shares from 3.5 million shares, and raising his holdings in Genworth Financial Inc to 9 million shares from 3.9 million shares.
-
MTG will only pull back when the housing market pulls back. We are in the sweet spot of the March to August housing numbers. But even then, the pent up demand may take us well into next year until we hit the next sweet spot.
-
For those of you who are "selling MTG or RDN at this level" to take a little profit and plan on getting back in IF there is a pull back, what are you thinking? These companies will steadily climb for longer than a year and a day and at that point you will have not only made a lot of money but you will have saved a lot of money.